Michael King analyst

Currently out of the existing stock ratings of Michael King, 107 are a BUY (97.27%), 3 are a HOLD (2.73%).

Michael King

Work Performance Price Targets & Ratings Chart

Analyst Michael King works with a stock forecast success ratio of 38.65% fulfilled within 109.68 days on average. Previously, Michael King worked at HCWAINWRIGHT.

Michael King’s has documented 207 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on SONN, Sonnet Biotherapeutics Holdings at 23-Aug-2023.

Wall Street Analyst Michael King

Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/25/2021. The price target of $111 was fulfilled within 3 days with a profit of $22.17 (24.96%) receiving and performance score of 83.19.

Average potential price target upside

ALNY Alnylam Pharmaceuticals LTRN Lantern Pharma AGIO Agios Pharm ANAB AnaptysBio CELG Celgene COGT Cogent Biosciences EXEL Exelixis INFI Infinity Pharmaceuticals KTRA Kintara Therapeutics NTLA Intellia Therapeutics REGN Regeneron Pharmaceuticals AGEN Agenus BMEA Biomea Fusion CMPX Compass Therapeutics . VINC Vincerx Pharma XNCR Xencor SONN Sonnet Biotherapeutics Holdings JSPR Jasper Therapeutics CALA Calithera Biosciences HOWL Werewolf Therapeutics SYRS Syros Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

234

$79.61 (51.56%)

234

1 days ago

0/3 (0%)

$79.61 (51.56%)

Buy

235

$80.61 (52.21%)

235

1 months 8 days ago

2/14 (14.29%)

$85.31 (56.99%)

149

Buy

227

$72.61 (47.03%)

237

1 months 12 days ago

14/22 (63.64%)

$80 (54.42%)

171

Hold

161

$6.61 (4.28%)

171

1 months 12 days ago

2/2 (100%)

$14 (9.52%)

5

Buy

225

$70.61 (45.73%)

250

1 months 12 days ago

2/6 (33.33%)

$78 (53.06%)

435

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Michael King?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?